"The conference and the one2one meetings at our Medtech Market Insight USA, has shown that there are substantial interest among Norwegian medtech companies to build relations towards the Medtech industry and R&D in USA, and that our industry aligns well with the expertise present in the Minneapolis market", says Kathrine Myhre, CEO Oslo Medtech.
“The combination of Norwegian experience in the US market with an cross section of US-based experts and practitioners went extremely well”, says Kermit Nash at Gray Plant Mooty, partner for the event.
One of the key note speakers and US market expert, Kermit Nash says after the conference and one2one meetings that “….we met companies that did not feel they had put together enough effort and pieces of their US strategy to be thinking seriously about the US market. The case is that several of the companies have great technology, and, with some guidance and key leadership, are ready to consider making the next serious step to enter the US market”.
Strategic connection to the US
During the conference, about 70 meetings between participating companies and US-based experts were conducted. The participants believe that there was value provided to each company that participated. Tagarno and Med-Storm share their experience.
Said by participants
“We had three one-2-one meetings during the Medtech Market Insight Event. The meetings were very beneficial to us. The highly qualified American experts were very enthusiastic and open-minded and we got good counseling on various subjects of great interest to us. Among other things, we got very useful feedback on our product and we had a good talk about the pros and cons of different distribution structures. What was really great was the American experts´ willingness to help us create good contacts in the US. To sum up, the meetings gave us new insights and good contacts”.
Rikke Thea Fabricius-Rømer, Business Developer New Business, TAGARNO AS
“We met several of the US delegates and were impressed of their extensive knowledge in their fields. Of the meetings especially Mr Caleb DesRosiers, was particularly helpful. Part of our business strategy has to be modified.
To conclude, I am convinced that such an event brings several of the companies closer to execution in a US health market”.
J.O.Gran, CEO Med-Storm
"I am very pleased with the seminar, it gave good opportunity to get in touch with the typical resources in the U.S. that companies need in a commercialization phase aimed at the United States".
Trond Stadheim, CEO dPCom
The presentations from the conference are
available here. You will also find the contact information to the US experts at
our webpage.
